Chirevo cheAmerican Cancer Society's (ACS) Cancer Chokwadi & Figures 2022, chakaburitswa nhasi, chinoratidza kuti makore mashanu ekupona kwegomarara repancreatic akawedzera kubva pagumi kusvika gumi nerimwe%. Nguva yekupedzisira iyo chiyero chekupona kwegomarara repancreatic yakawedzera yaive muna 10 payakatanga kusvika manhamba maviri.
Nepo kuwedzera uku kwezvikamu zvishanu kubva muzana mumakore gumi apfuura zvichiratidza kufambira mberi kwakakosha, iyo Chokwadi & Nhamba mushumo inoratidzawo inofungidzirwa kuti 62,210 vekuAmerica vachaonekwa vaine pancreatic cancer muna 2022, inova kuwedzera kweinoda kusvika 3% kubva gore rapfuura. Sekureva kwemushumo, nepo gomarara repancreatic pari zvino riri rechigumi rinowanzo zivikanwa gomarara muUS, rinoramba riri rechitatu rinotungamira zvikonzero zvekufa zvine chekuita negomarara. Vanoda kusvika 10 vekuAmerica vari kutarisirwa kufa nechirwere ichi gore rino.
Kubva payakavambwa muna 1999, iyo Pancreatic Cancer Action Network (PanCAN) yakatora nzira yakazara yekurwisa gomarara repasi rose pamativi ese - kusanganisira tsvakiridzo, zvirongwa zvekiriniki, mabasa evarwere uye kurudziro - kuitira kuvandudza mhedzisiro yevarwere uye kuwedzera pese. kupona.
"Tinofara kuona kufambira mberi kwehuwandu hwemakore mashanu ekupona. Kunyangwe chikamu chimwe muzana chinomiririra mazana evarwere vegomarara repancreatic vanozove nenguva yakawanda nevadikani vavo, asi isu hatigone kugumira ipapo, "akadaro Julie Fleshman, JD, MBA, mutungamiri wePanCAN uye CEO. "11% ndiyo ichiri yakaderera yekurarama kwekenza huru, saka pachine chido chekuwedzera mari, tsvakiridzo nekuziva apo isu tinoshanda kusimudzira mhedzisiro yevarwere."
Sezvakaitika kare, huwandu hwekupona kwegomarara repancreatic hwakadzikira nekuti, pasina nzira yekukurumidza yekuona uye kazhinji zviratidzo zvisina kujeka, zvinowanzoonekwa zvanonoka kana chirwere chatopararira. Panguva ino, kuvhiyiwa hakuchagoneki uye pari zvino kune mashoma ekurapa chemotherapy nzira, zvinosimbisa kudiwa kwekukasika kwekukurumidza kuvhenekwa nzira yepancreatic cancer pamwe netsva uye nani nzira dzekurapa dzevarwere.
Tichitarisa kune ramangwana, PanCAN yakaisa chinangwa chekuda kuona huwandu hwemakore mashanu hwekupona huchikwira kusvika pamakumi maviri muzana panosvika 20.
"Kunyangwe chinangwa ichi chiri kureba, hazvisi kunze kwenzvimbo inogona kuitika," akadaro Lynn Matrisian, PhD, MBA, mukuru weSainzi wePanCAN. "Pane nzira mbiri huru dzatinovandudza kurarama. Imwe ndeyekukasika kuonekwa. Isu tinobata gomarara kare, tichipa vanhu mukana wakawanda wekuvhiyiwa, mikana yakawanda yekurirapa nekemotherapeutic agents. Imwe nzira yatinonatsiridza nayo kurarama ndeyekuita kuti chemotherapy uye kumwe kurapwa kuve nani. "
Kubva 2003, PanCAN yakaisa mari inodarika madhora zana nemakumi mana nepfumbamwe mukutsvaga, neimwe madhora miriyoni makumi maviri nemasere inotarisirwa gore rino remari. Izvi zvinosanganisira mazana maviri nesere erubatsiro rwesainzi munyika yese pamwe nehurongwa hwakakura hwekutsvagisa hwakadai sePanCAN's Precision PromiseSM Clinical Trial, iyo inotarisira kukurumidzira kubvumidzwa kwemaitiro matsva ekurapa varwere vegomarara repancreatic uye PanCAN's Early Detection Initiative, iyo inotarisira kugadzira chirongwa. zano rekuongorora gomarara repancreatic nekukurumidza kana kuvhiyiwa kuchiri kuitika, zvichitungamira kune zviri nani mhedzisiro yemurwere.
Kutsigira vese varwere vepancreatic cancer uye nekumhanyisa kufambira mberi, PanCAN inopa yemahara, yemunhu rutsigiro rwemurwere kuburikidza nechirongwa chayo chePatient Services, kusanganisira Clinical Trial Finder inopa mukana kune yazvino uye yakazara pancreatic cancer yekiriniki dhatabhesi muUnited States.
ZVOKUBVA MUNYAYA INO:
- This includes 218 grants for scientists across the country as well as large-scale research initiatives such as PanCAN’s Precision PromiseSM Clinical Trial, which seeks to accelerate the approval of new treatment options for pancreatic cancer patients and PanCAN’s Early Detection Initiative, which hopes to develop a strategy to diagnose pancreatic cancer early when surgery is still possible, leading to better patient outcomes.
- Kubva payakavambwa muna 1999, iyo Pancreatic Cancer Action Network (PanCAN) yakatora nzira yakazara yekurwisa gomarara repasi rose pamativi ese - kusanganisira tsvakiridzo, zvirongwa zvekiriniki, mabasa evarwere uye kurudziro - kuitira kuvandudza mhedzisiro yevarwere uye kuwedzera pese. kupona.
- At this point, surgery is no longer a possibility and there are currently limited chemotherapy treatment options, underscoring the urgent need for an early detection method for pancreatic cancer as well as new and better treatment options for patients.
